(Q44499492)

3 December 2017

Modulation of the LDL receptor and LRP levels by HIV protease inhibitors (English)

1 reference

3 December 2017

Huan Tran

1

1 reference

3 December 2017

Susan Robinson

series ordinal

2

1 reference

3 December 2017

Irina Mikhailenko

series ordinal

3

1 reference

3 December 2017

Dudley K Strickland

series ordinal

4

1 reference

3 December 2017

1 July 2003

1 reference

Journal of Lipid Research

3 December 2017

1 reference

3 December 2017

44

1 reference

3 December 2017

10

1 reference

3 December 2017

1859-1869

1 reference

Dual protease inhibitor therapy in HIV-infected patients: pharmacologic rationale and clinical benefits

3 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

HIV protease inhibitors stimulate hepatic triglyceride synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Select HIV protease inhibitors alter bone and fat metabolism ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Receptor-Mediated Control of Cholesterol Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

LRP: a multifunctional scavenger and signaling receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function betwenn LRP and the PDGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

LRP: role in vascular wall integrity and protection from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Localization and regulation of the human very low density lipoprotein/apolipoprotein-E receptor: trophoblast expression predicts a role for the receptor in placental lipid transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Transport-Dependent Proteolysis of SREBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Regulation of LDL receptor, apoB, and apoE protein and mRNA in Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Regulation of the activity of the low density lipoprotein receptor in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Heterozygous familial hypercholesterolemia: Failure of normal allele to compensate for mutant allele at a regulated genetic locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Development of cervical fat pads following therapy with human immunodeficiency virus type 1 protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Asparagine-proline sequence within membrane-spanning segment of SREBP triggers intramembrane cleavage by site-2 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

The action of molecular chaperones in the early secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

ER stress response: getting the UPR hand on misfolded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Fat distribution and metabolic changes in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Vascular complications associated with use of HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Vascular complications associated with use of HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Vascular and lipid syndromes in selected HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Recognition of alpha 2-macroglobulin by the low density lipoprotein receptor-related protein requires the cooperation of two ligand binding cluster regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Structure of the low-density lipoprotein receptor-related protein (LRP) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

The 5'-flanking region of the alpha 2MR/LRP gene contains an enhancer-like cluster of Sp1 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200487-JLR200

10.1194/JLR.M200487-JLR200

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference